Clinical Trials Directory

Trials / Unknown

UnknownNCT05371795

Comparison on Radiotherapy Permanent Skin Marking With Lancets and an Electric Marking Device

Research Study: Tattooing of Skin Landmarks in Radiotherapy: Comparison Between the System Traditional and Comfort Marker 2.0® (COMFORTATTOO)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Instituto Portugues de Oncologia, Francisco Gentil, Porto · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Comparison on radiotherapy skin set-up markings with lancets versus Comfort Marker 2.0®

Detailed description

A Prospective, unicentric, randomized, controlled, parallel, double-blinded, cohort study comparing radiotherapy skin set-up markings with lancets versus electric marking device (Comfort Marker 2.0® by CIVCO®)

Conditions

Interventions

TypeNameDescription
DEVICEComfort Marker 2.0The set-up markings are created during the simulation session, after the CT simulation is acquired. For the experimental group, patients' markings are tattooed using an electric marking device developed for set-up marking, the Comfort Marker 2.0® (CM), designed by CIVCO medical solutions, using the 0.2mm deep application depth and the brand-included black pigment. After cleaning the excess ink, if the tattooing was considered unsuccessful, the process was repeated. Markings arrangement followed our departmental protocol. No limit on the maximum number of cutaneous reference points is specified.
DEVICELancetsThe set-up markings are created during the simulation session, after the CT simulation is acquired. For the control group, patients' markings are tattooed using a 28-gauge disposable lancet and india ink. After cleaning the excess ink, if the tattooing was considered unsuccessful, the process was repeated. Markings arrangement followed our departmental protocol. No limit on the maximum number of cutaneous reference points is specified.

Timeline

Start date
2021-10-18
Primary completion
2022-03-11
Completion
2022-09-01
First posted
2022-05-12
Last updated
2022-06-10

Locations

1 site across 1 country: Portugal

Source: ClinicalTrials.gov record NCT05371795. Inclusion in this directory is not an endorsement.